TUI AG

  • WKN: TUAG00
  • ISIN: DE000TUAG000
  • Land: Germany

Nachricht vom 25.10.2021 | 16:27

TUI AG: Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

TUI AG (TUI)
25-Oct-2021 / 16:27 CET/CEST
Dissemination of a Regulatory Announcement, transmitted by EQS Group.
The issuer is solely responsible for the content of this announcement.

1. Details of the person discharging managerial responsibilities / person closely associated

a) Name
Name and legal form: Unifirm Limited

2. Reason for the notification

a) Position / status
Person closely associated with:
Title:
First name: Alexey A.
Last name(s): Mordashov
Position: Member of the administrative or supervisory body

b) Initial notification

3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a) Name
TUI AG

b) LEI
529900SL2WSPV293B552 

4. Details of the transaction(s)

a) Description of the financial instrument, type of instrument, identification code
Type: Share
Description: Depositary Interests for underlying TUI AG Ordinary Shares DE000TUAG000

b) Nature of the transaction
Acquisition

c) Price(s) and volume(s)
Price(s) Volume(s)
2.3395 GBP 4747355.51 GBP

d) Aggregated information
Price Aggregated volume
2.3395 GBP 4747355.51 GBP

e) Date of the transaction
2021-10-22; UTC±0

f) Place of the transaction
Outside a trading venue




show this

GBC im Fokus

IGEA Pharma N.V. Realignment to CBD extraction

The goal is to become the quality and cost leader in the field of CBD in Europe. To this end, a GMP pharma compliant plant is being built in Switzerland. The supercritical CO2 extraction process is to be used to achieve the highest standard of quality. The CBD market is growing strongly and with the focus on quality leadership and pure extraction, IGEA Pharma's new business model should be able to occupy an attractive niche market. With the proprietary supercritical CO2-extraction technology, other markets such as vanilla, rose or rosemary can be developed in the medium term. Based on our DCF model, we have determined a fair value of € 1.05 (CHF 1.13) per share and assign a BUY rating.

News im Fokus

Infineon Technologies AG: Aufsichtsrat beruft Jochen Hanebeck zum Nachfolger von Dr. Reinhard Ploss als Vorstandsvorsitzenden von Infineon

25. November 2021, 17:45

Aktuelle Research-Studie

3U HOLDING AG

Original-Research: 3U HOLDING AG (von GSC Research GmbH): Halten

26. November 2021